Global Pharmaceutical Impurity Testing Service Market 2025 by Company, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Pharmaceutical Impurity Testing Service market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Pharmaceutical impurity testing service refers to the analysis and identification of impurities present in pharmaceutical products. Impurities can be defined as any component present in the drug substance or drug product that is not the desired chemical entity. These impurities can be generated during the manufacturing process, degradation of the drug substance or product, or even from the packaging materials.
Pharmaceutical impurity testing is crucial to ensure the safety, efficacy, and quality of pharmaceutical products. It helps in identifying and quantifying impurities, including organic impurities, inorganic impurities, residual solvents, and potential genotoxic impurities. The testing is performed using various analytical techniques such as high-performance liquid chromatography (HPLC), gas chromatography (GC), mass spectrometry (MS), and nuclear magnetic resonance (NMR).
The impurity testing service is typically provided by specialized laboratories or contract research organizations (CROs) that have expertise in pharmaceutical analysis. These service providers follow regulatory guidelines and standards, such as those set by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), to ensure accurate and reliable results.
The impurity testing service helps pharmaceutical companies in complying with regulatory requirements, such as those outlined in the United States Pharmacopeia (USP) and European Pharmacopoeia (EP). It also assists in the development and optimization of manufacturing processes, as well as in the investigation of product failures or quality issues.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Pharmaceutical Impurity Testing Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharmaceutical Impurity Testing Service market size and forecasts, in consumption value ($ Million), 2020-2031
Global Pharmaceutical Impurity Testing Service market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Pharmaceutical Impurity Testing Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Pharmaceutical Impurity Testing Service market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Impurity Testing Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Impurity Testing Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alfa Chemistry, Eurofins Scientific, Intertek, Element, Nelson Laboratories, Charles River, Creative Proteomics, SGS, Drug Development Solutions, Selvita, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Pharmaceutical Impurity Testing Service market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Biopharmacuetical Process-related Impurities Analysis
Organic Impurities Analysis
Solvent Residual Analysis
Elemental Impurities Analysis
Genotoxic Impurities Analysis
Other
Market segment by Application
Pharmaceutical
Health Products
Other
Market segment by players, this report covers
Alfa Chemistry
Eurofins Scientific
Intertek
Element
Nelson Laboratories
Charles River
Creative Proteomics
SGS
Drug Development Solutions
Selvita
Auriga Research
BHP
Jordi Labs
GBA Group
Synergy Health Utrecht
LYF Research
CPL
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmaceutical Impurity Testing Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical Impurity Testing Service, with revenue, gross margin, and global market share of Pharmaceutical Impurity Testing Service from 2020 to 2025.
Chapter 3, the Pharmaceutical Impurity Testing Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Pharmaceutical Impurity Testing Service market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical Impurity Testing Service.
Chapter 13, to describe Pharmaceutical Impurity Testing Service research findings and conclusion.
Pharmaceutical impurity testing service refers to the analysis and identification of impurities present in pharmaceutical products. Impurities can be defined as any component present in the drug substance or drug product that is not the desired chemical entity. These impurities can be generated during the manufacturing process, degradation of the drug substance or product, or even from the packaging materials.
Pharmaceutical impurity testing is crucial to ensure the safety, efficacy, and quality of pharmaceutical products. It helps in identifying and quantifying impurities, including organic impurities, inorganic impurities, residual solvents, and potential genotoxic impurities. The testing is performed using various analytical techniques such as high-performance liquid chromatography (HPLC), gas chromatography (GC), mass spectrometry (MS), and nuclear magnetic resonance (NMR).
The impurity testing service is typically provided by specialized laboratories or contract research organizations (CROs) that have expertise in pharmaceutical analysis. These service providers follow regulatory guidelines and standards, such as those set by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), to ensure accurate and reliable results.
The impurity testing service helps pharmaceutical companies in complying with regulatory requirements, such as those outlined in the United States Pharmacopeia (USP) and European Pharmacopoeia (EP). It also assists in the development and optimization of manufacturing processes, as well as in the investigation of product failures or quality issues.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Pharmaceutical Impurity Testing Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharmaceutical Impurity Testing Service market size and forecasts, in consumption value ($ Million), 2020-2031
Global Pharmaceutical Impurity Testing Service market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Pharmaceutical Impurity Testing Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Pharmaceutical Impurity Testing Service market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Impurity Testing Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Impurity Testing Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alfa Chemistry, Eurofins Scientific, Intertek, Element, Nelson Laboratories, Charles River, Creative Proteomics, SGS, Drug Development Solutions, Selvita, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Pharmaceutical Impurity Testing Service market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Biopharmacuetical Process-related Impurities Analysis
Organic Impurities Analysis
Solvent Residual Analysis
Elemental Impurities Analysis
Genotoxic Impurities Analysis
Other
Market segment by Application
Pharmaceutical
Health Products
Other
Market segment by players, this report covers
Alfa Chemistry
Eurofins Scientific
Intertek
Element
Nelson Laboratories
Charles River
Creative Proteomics
SGS
Drug Development Solutions
Selvita
Auriga Research
BHP
Jordi Labs
GBA Group
Synergy Health Utrecht
LYF Research
CPL
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmaceutical Impurity Testing Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical Impurity Testing Service, with revenue, gross margin, and global market share of Pharmaceutical Impurity Testing Service from 2020 to 2025.
Chapter 3, the Pharmaceutical Impurity Testing Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Pharmaceutical Impurity Testing Service market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical Impurity Testing Service.
Chapter 13, to describe Pharmaceutical Impurity Testing Service research findings and conclusion.
Table of Contents
138 Pages
- 1 Market Overview
- 2 Company Profiles
- 3 Market Competition, by Players
- 4 Market Size Segment by Type
- 5 Market Size Segment by Application
- 6 North America
- 7 Europe
- 8 Asia-Pacific
- 9 South America
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
